Clinical Trial: A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment in Orthopedic Surgery

U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07442877) titled 'A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment in Orthopedic Surgery' on Feb. 11.

Brief Summary: This is a multi-center, randomized, double-blind, placebo/active-controlled study. 160 subjects undergoing orthopedic surgery under general anesthesia are planned to be enrolled and randomized into the HSK21542 group, morphine group, and placebo group.

Study Start Date: Sept. 13, 2024

Study Type: INTERVENTIONAL

Condition: Postoperative Pain Management

Intervention: DRUG: HSK21542 dose level 1

Patients administrated with HSK21542 dose level 1

DRUG: HSK21542 dose...